Despite 2018's successes in the neurology market, research and development (R&D) setbacks in the field of Alzheimer's disease continue to ... read more
Alzheimer's disease drug failures plague R&D in neurology, says analyst, but migraine does better
Alzheimer’s disease drug failures plague R&D in neurology, says analyst, but migraine does better